Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
Long-lasting HIV injection is a step closer after second GSK study
Reuters
Wed, 10/31/18 - 09:53 am
vaccines
GSK
HIV
cabotegravir
rilpivirine
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
CP Wire
Tue, 10/30/18 - 10:22 am
Janssen
JNJ
Symtuza
HIV
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients
Tue, 10/30/18 - 09:53 am
Janssen
JNJ
Symtuza
HIV
Gilead's HIV portfolio soars, but is it enough to combat falling HCV sales?
Fierce Pharma
Fri, 10/26/18 - 08:42 pm
Gilead Sciences
HIV
Inovio touts intradermal delivery of HIV vaccine
Drug Delivery Business News
Fri, 10/26/18 - 11:53 am
Invovio
HIV
vaccines
Pennvax-GP
US filing for ViiV’s two-drug, single pill HIV treatment
Pharma Times
Mon, 10/22/18 - 05:03 pm
ViiV
FDA
HIV
dolutegravir/lamivudine
Gilead, Aelix ally to trial HIV-suppressing combination
Fierce Biotech
Thu, 10/18/18 - 11:20 am
Gilead Sciences
Aelix Therapeutics
vaccines
antiretrovirals
HIV
Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study
Pharmaceutical Business Review
Thu, 10/4/18 - 09:42 am
Gilead Sciences
Biktarvy
HIV-1
HIV
Why Payers Sometimes Restrict Access To Single Tablet Regimens For HIV Patients
Forbes
Mon, 10/1/18 - 09:45 am
HIV
antiretrovirals
payers
T-cell therapy for eradicating HIV reservoirs proves safe in small study
Fierce Biotech
Sat, 09/22/18 - 05:29 pm
HIV
immunotherapy
What's Next for Gilead Sciences After Its Latest Clinical Success
Motley Fool
Thu, 09/13/18 - 12:00 pm
Gilead Sciences
John Milligan
HIV
NASH
filgotinib
Needed vaccines against HIV, malaria and tuberculosis unlikely to launch at current funding levels: study
Fierce Pharma
Mon, 09/10/18 - 11:00 pm
drug development
vaccines
HIV
tuberculosis
malaria
FDA approves two new HIV drugs from Merck
Reuters
Fri, 08/31/18 - 10:57 am
Merck
HIV
FDA
Delstrigo
Pifeltro
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Thu, 08/16/18 - 10:09 am
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
Long-acting injection boosts hopes for GSK's HIV business
Yahoo/Reuters
Wed, 08/15/18 - 09:40 am
GSK
HIV
AIDS
cabotegravir
rilpivirine
ViiV
AIDS health group brings Gilead patent skirmish to Supreme Court
Fierce Pharma
Tue, 08/14/18 - 11:57 am
Gilead Sciences
AIDS
HIV
TAF
Supreme Court
Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It
Forbes
Tue, 08/7/18 - 11:42 pm
Gilead Sciences
HIV
Truvada
drug ads
Express Scripts to Drop Big Sellers From AbbVie, Gilead in 2019
Bloomberg
Tue, 08/7/18 - 11:24 am
Express Scripts
PBMs
Gilead Sciences
HIV
Atripla
AbbVie
Mavyret
hepatitis C
China Approves Gilead's Genvoya for HIV-1 Infection
CP Wire
Mon, 08/6/18 - 09:47 am
Gilead Sciences
China
Genvoya
HIV
China Approves Gilead's Genvoya for HIV-1 Infection
Mon, 08/6/18 - 09:35 am
Gilead Sciences
Genvoya
HIV
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »